# Nova ratio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nova-ratio

- Industry: Software
- Headquarters: Germany
- Website: www.nova-ratio.de
- Total disclosed funding: $1.3M
- Latest round: Series A (Apr 1, 2005)
- Investors on record: 2

## About

Nova Ratio delivers health-focused products and insights, specializing in nutritional supplements and innovative fitness equipment aimed at enhancing well-being and athletic performance.Founded in 1995 in Germany, Nova Ratio focuses on health and fitness solutions. The company has raised USD 1.3 mn in its Series A funding round in April 2005, with notable investors including EVP Capital Management and DTCP Growth. The firm has engaged in one deal to date, with its most recent funding effort contributing to its ongoing development and market presence.Nova Ratio specializes in delivering comprehensive insights and products focused on health, fitness, and well-being. The company's primary offerings include nutritional supplements, particularly magnesium bisglycinate, which supports various bodily functions and promotes better sleep and stress reduction. Additionally, Nova Ratio provides training materials aimed at enhancing athletic performance, such as SMMASH ThermoPerformanceMaterial technology, applicable in various sports training environments. The company also explores innovative fitness equipment like bumper plates, catering to weightlifting and functional training enthusiasts. Nova Ratio serves a diverse clientele ranging from amateur athletes to seasoned professionals, primarily targeting markets in Europe and North America, where there is a growing demand for health-oriented products and performance-enhancing technologies.Revenue generation at Nova Ratio is structured around direct-to-consumer transactions and partnerships with retailers that distribute their products. Customers purchase items directly through the company's platform or through authorized retailers, ensuring wide availability across various regions. The company also engages in subscription services for ongoing nutritional support and training guidance, which fosters customer loyalty and repeat business. Although specific pricing details for individual products are not disclosed, the company’s flagship offerings, such as magnesium bisglycinate and performance-enhancing training gear, are tailored to meet the needs of its target audience while remaining competitive within the marketplace. This structured approach to revenue facilitates a steady stream of income as consumers increasingly prioritize health and fitness solutions.Nova Ratio plans to leverage its recent funding of USD 1.3 mn raised in April 2005 to enhance product development and expand its market reach. The company aims to introduce new products in the upcoming year, focusing on innovative nutritional supplements and fitness equipment. Additionally, Nova Ratio intends to target new geographic regions in Europe and North America by 2025, capitalizing on the rising demand for health-oriented products.

## Funding rounds

- Series A, Apr 1, 2005, $1.3M — EVP Capital Management, DTCP

## Investors

- EVP Capital Management — Series A
- DTCP — Series A